{"id":597394,"date":"2022-04-25T21:38:02","date_gmt":"2022-04-25T21:38:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=597394"},"modified":"2022-04-25T21:38:02","modified_gmt":"2022-04-25T21:38:02","slug":"optic-neuritis-market-to-grow-substantially-during-the-forecast-period-estimates-delveinsight-key-companies-questcor-biogen-mitochon-pharmaceuticals-and-noveome-biotherapeutics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/optic-neuritis-market-to-grow-substantially-during-the-forecast-period-estimates-delveinsight-key-companies-questcor-biogen-mitochon-pharmaceuticals-and-noveome-biotherapeutics_597394.html","title":{"rendered":"Optic Neuritis Market to Grow Substantially During the Forecast Period – Estimates DelveInsight | Key Companies – Questcor, Biogen, Mitochon Pharmaceuticals, and Noveome Biotherapeutics"},"content":{"rendered":"
\n
\"Optic<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Optic Neuritis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Optic Neuritis Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/div>\n

The Optic Neuritis market report<\/strong> covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Optic<\/p>\n

Optic Neuritis: An Overview<\/strong><\/p>\n

The American Academy of Ophthalmology defined Optic Neuritis (ON) as the swelling of the eye’s optic nerve. The optic nerve carries light signals from the back of the eye to the brain so that a person can see. A person cannot see clearly if the optic nerve is swollen, damaged, or infected. <\/em><\/p>\n

It is an acute rare disorder that usually occurs in one eye, and is characterized by symptoms including blurring of vision, a loss of part or all of central vision, reduced color vision, and dimness of vision. Most patients with ON have eye pain which characteristically worsens with movement of the eye.<\/em><\/p>\n

Optic Neuritis Market Key Facts<\/strong><\/p>\n